PMC:7205724 / 825-1053 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"57","span":{"begin":25,"end":34},"obj":"Species"},{"id":"58","span":{"begin":66,"end":74},"obj":"Species"},{"id":"59","span":{"begin":171,"end":178},"obj":"Species"},{"id":"69","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"70","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:9606"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":25,"end":29},"obj":"Disease"},{"id":"T11","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"T12","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":35,"end":38},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":140,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sample-CHEBI

    {"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T5","span":{"begin":140,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T11","span":{"begin":25,"end":34},"obj":"Species"},{"id":"T12","span":{"begin":87,"end":95},"obj":"Species"},{"id":"T13","span":{"begin":204,"end":212},"obj":"Species"}],"attributes":[{"id":"A11","pred":"ncbi_taxonomy_id","subj":"T11","obj":"NCBItxid:2697049"},{"id":"A12","pred":"ncbi_taxonomy_id","subj":"T12","obj":"NCBItxid:2697049"},{"id":"A13","pred":"ncbi_taxonomy_id","subj":"T13","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T14","span":{"begin":97,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"57","span":{"begin":25,"end":34},"obj":"Species"},{"id":"58","span":{"begin":66,"end":74},"obj":"Species"},{"id":"69","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"59","span":{"begin":171,"end":178},"obj":"Species"},{"id":"70","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"pubann:denotes","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"pubann:denotes","subj":"58","obj":"Tax:9606"},{"id":"A69","pred":"pubann:denotes","subj":"69","obj":"MESH:C000657245"},{"id":"A59","pred":"pubann:denotes","subj":"59","obj":"Tax:9606"},{"id":"A70","pred":"pubann:denotes","subj":"70","obj":"MESH:C000657245"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T129","span":{"begin":6,"end":16},"obj":"NNS"},{"id":"T130","span":{"begin":17,"end":24},"obj":"IN"},{"id":"T131","span":{"begin":25,"end":34},"obj":"NN"},{"id":"T132","span":{"begin":35,"end":38},"obj":"VBZ"},{"id":"T133","span":{"begin":39,"end":44},"obj":"VBN"},{"id":"T134","span":{"begin":45,"end":54},"obj":"JJ"},{"id":"T135","span":{"begin":55,"end":62},"obj":"NNS"},{"id":"T136","span":{"begin":63,"end":65},"obj":"IN"},{"id":"T137","span":{"begin":66,"end":74},"obj":"NNS"},{"id":"T138","span":{"begin":75,"end":79},"obj":"IN"},{"id":"T139","span":{"begin":80,"end":86},"obj":"JJ"},{"id":"T140","span":{"begin":87,"end":95},"obj":"NN"},{"id":"T141","span":{"begin":97,"end":101},"obj":"RB"},{"id":"T142","span":{"begin":101,"end":102},"obj":"-COMMA-"},{"id":"T143","span":{"begin":103,"end":107},"obj":"NNP"},{"id":"T144","span":{"begin":107,"end":108},"obj":"-COMMA-"},{"id":"T145","span":{"begin":109,"end":117},"obj":"VBN"},{"id":"T146","span":{"begin":118,"end":122},"obj":"IN"},{"id":"T147","span":{"begin":123,"end":136},"obj":"NN"},{"id":"T148","span":{"begin":137,"end":139},"obj":"IN"},{"id":"T149","span":{"begin":140,"end":155},"obj":"NNS"},{"id":"T150","span":{"begin":155,"end":156},"obj":"-COMMA-"},{"id":"T151","span":{"begin":157,"end":162},"obj":"MD"},{"id":"T152","span":{"begin":163,"end":170},"obj":"VB"},{"id":"T153","span":{"begin":171,"end":178},"obj":"NN"},{"id":"T154","span":{"begin":179,"end":187},"obj":"NNS"},{"id":"T155","span":{"begin":189,"end":197},"obj":"NN"},{"id":"T156","span":{"begin":198,"end":203},"obj":"VBZ"},{"id":"T157","span":{"begin":204,"end":212},"obj":"NN"},{"id":"T158","span":{"begin":213,"end":215},"obj":"TO"},{"id":"T159","span":{"begin":216,"end":224},"obj":"JJ"}],"relations":[{"id":"R122","pred":"arg1Of","subj":"T129","obj":"T130"},{"id":"R123","pred":"arg2Of","subj":"T131","obj":"T130"},{"id":"R125","pred":"arg2Of","subj":"T133","obj":"T132"},{"id":"R127","pred":"arg2Of","subj":"T135","obj":"T133"},{"id":"R128","pred":"arg1Of","subj":"T135","obj":"T134"},{"id":"R129","pred":"arg1Of","subj":"T133","obj":"T136"},{"id":"R130","pred":"arg2Of","subj":"T137","obj":"T136"},{"id":"R131","pred":"arg1Of","subj":"T137","obj":"T138"},{"id":"R132","pred":"arg2Of","subj":"T140","obj":"T138"},{"id":"R133","pred":"arg1Of","subj":"T140","obj":"T139"},{"id":"R134","pred":"arg1Of","subj":"T152","obj":"T141"},{"id":"R135","pred":"arg1Of","subj":"T152","obj":"T142"},{"id":"R136","pred":"arg1Of","subj":"T143","obj":"T144"},{"id":"R137","pred":"arg2Of","subj":"T143","obj":"T145"},{"id":"R138","pred":"arg1Of","subj":"T145","obj":"T146"},{"id":"R139","pred":"arg2Of","subj":"T147","obj":"T146"},{"id":"R140","pred":"arg1Of","subj":"T147","obj":"T148"},{"id":"R141","pred":"arg2Of","subj":"T149","obj":"T148"},{"id":"R142","pred":"arg1Of","subj":"T152","obj":"T150"},{"id":"R143","pred":"arg1Of","subj":"T143","obj":"T151"},{"id":"R144","pred":"arg2Of","subj":"T152","obj":"T151"},{"id":"R145","pred":"arg1Of","subj":"T143","obj":"T152"},{"id":"R146","pred":"arg2Of","subj":"T154","obj":"T152"},{"id":"R147","pred":"arg1Of","subj":"T154","obj":"T153"},{"id":"R148","pred":"arg1Of","subj":"T155","obj":"T156"},{"id":"R149","pred":"arg2Of","subj":"T157","obj":"T156"},{"id":"R150","pred":"arg1Of","subj":"T156","obj":"T158"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T10","span":{"begin":25,"end":34},"obj":"Disease"},{"id":"T11","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"T12","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T14","span":{"begin":97,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. Evidence links COVID-19 to variable deg"}